Blood based biomarkers beyond genomics for lung cancer screening

被引：38
作者：
Hanash, Samir M. [1 ]
Ostrin, Edwin Justin [2 ]
Fahrmann, Johannes F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2018年 / 7卷 / 03期
关键词：
Biomarkers; proteins; metabolites; autoantibodies; RISK PREDICTION MODEL; DOSE COMPUTED-TOMOGRAPHY; SERUM BIOMARKER; EARLY-DIAGNOSIS; PANEL; VALIDATION; PLASMA; ADENOCARCINOMA; IDENTIFICATION; METABOLOMICS;
D O I：
10.21037/tlcr.2018.05.13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
While there is considerable interest at the present time in the development of so-called liquid biopsy approaches for cancer detection based notably on circulating tumor DNA, there are other types of potential biomarkers that show promise for lung cancer screening and early detection. Here we review approaches and some of the promising markers based on proteomics, metabolomics and the immune response to tumor antigens in the form of autoantibodies.
引用
收藏
页码：327 / 335
页数：9
相关论文
共 87 条
  • [41] Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma
    Louis, Evelyne
    Adriaensens, Peter
    Guedens, Wanda
    Bigirumurame, Theophile
    Baeten, Kurt
    Vanhove, Karolien
    Vandeurzen, Kurt
    Darquennes, Karen
    Vansteenkiste, Johan
    Dooms, Christophe
    Shkedy, Ziv
    Mesotten, Liesbet
    Thomeer, Michiel
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : 516 - 523
  • [42] Multiplexed Serum Biomarkers for the Detection of Lung Cancer
    Ma, Shenglin
    Wang, Wenzhe
    Xia, Bing
    Zhang, Shirong
    Yuan, Haining
    Jiang, Hong
    Meng, Wen
    Zheng, Xiaoliang
    Wang, Xiaoju
    [J]. EBIOMEDICINE, 2016, 11 : 210 - 218
  • [43] Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study
    Maeda, Jun
    Higashiyama, Masahiko
    Imaizumi, Akira
    Nakayama, Tomio
    Yamamoto, Hiroshi
    Daimon, Takashi
    Yamakado, Minoru
    Imamura, Fumio
    Kodama, Ken
    [J]. BMC CANCER, 2010, 10
  • [44] The Lung Reporting and Data System (LU-RADS): A Proposal for Computed Tomography Screening
    Manos, Dania
    Seely, Jean M.
    Taylor, Jana
    Borgaonkar, Joy
    Roberts, Heidi C.
    Mayo, John R.
    [J]. CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2014, 65 (02): : 121 - 134
  • [45] LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence
    Marcus, Michael W.
    Chen, Ying
    Raji, Olaide Y.
    Duffy, Stephen W.
    Field, John K.
    [J]. CANCER PREVENTION RESEARCH, 2015, 8 (06) : 570 - 575
  • [46] Evaluation of a Serum Lung Cancer Biomarker Panel
    Mazzone, Peter J.
    Wang, Xiao-Feng
    Han, Xiaozhen
    Choi, Humberto
    Seeley, Meredith
    Scherer, Richard
    Doseeva, Victoria
    [J]. BIOMARKER INSIGHTS, 2018, 13
  • [47] Development of an optimized multi-biomarker panel for the detection of lung cancer based on principal component analysis and artificial neural network modeling
    Miguel Flores-Fernandez, Jose
    Herrera-Lopez, Enrique J.
    Sanchez-Llamas, Francisco
    Rojas-Calvillo, Antonio
    Anel Cabrera-Galeana, Paula
    Leal-Pacheco, Gisela
    Guadalupe Gonzalez-Palomar, Maria
    Femat, R.
    Martinez-Velazquez, Moises
    [J]. EXPERT SYSTEMS WITH APPLICATIONS, 2012, 39 (12) : 10851 - 10856
  • [48] Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry
    Miyamoto, Suzanne
    Taylor, Sandra L.
    Barupal, Dinesh K.
    Taguchi, Ayumu
    Wohlgemuth, Gert
    Wikoff, William R.
    Yoneda, Ken Y.
    Gandara, David R.
    Hanash, Samir M.
    Kim, Kyoungmi
    Fiehn, Oliver
    [J]. METABOLITES, 2015, 5 (02) : 192 - 210
  • [49] Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study
    Muller, David C.
    Johansson, Mattias
    Brennan, Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) : 861 - U89
  • [50] Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003
123456789